← Back to Search

District health information package for Infectious Diseases (DESH Trial)

N/A
Waitlist Available
Led By Onil Bhattacharyya, MD, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All districts in India in existence in 2001
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five years
Awards & highlights

DESH Trial Summary

The purpose of this study is to assess the impact of disseminating information on comparative performance, along with actionable messages on how to improve health outcomes, to district-level decision-makers in India using a randomized, controlled design. This information should improve prioritization of health services by district health officers, budget allocation for health, and implementation of priority health services at the district level.

Eligible Conditions
  • Infectious Diseases
  • Cardiovascular Disease

DESH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

DESH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five years
This trial's timeline: 3 weeks for screening, Varies for treatment, and five years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage children 12-23 months vaccinated against measles
Percentage children <3 yrs with diarrhea in past 2 weeks given oral rehydration solution
Percentage facility-based births for the last child since 2007
Secondary outcome measures
Percentage community health centres with at least 1 surgeon or ob/gyn
Breast
Percentage public health centres with reagents, light microscope and lab technician for malaria blood smear
+2 more
Other outcome measures
Differences in any of primary and between Empowered Action Group and Assam (EAGA) states and non-EAGA states
Differences in any of primary and between measles-focus states and non-measles-focus states

DESH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: District health information packageExperimental Treatment1 Intervention
Group II: No InterventionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Lombard Insurance Global Poverty Action LabUNKNOWN
Canadian International Development AgencyOTHER_GOV
12 Previous Clinical Trials
899,631 Total Patients Enrolled
Unity Health TorontoLead Sponsor
540 Previous Clinical Trials
447,186 Total Patients Enrolled
1 Trials studying Infectious Diseases
550 Patients Enrolled for Infectious Diseases

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health
2009. "Promoting Evidence-Based Decision-Making in India: District Evaluation Study on Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01003587.
All > Health
~38 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top